Clinical Trials Logo

Filter by:
NCT ID: NCT05594134 Completed - Dental Plaque Clinical Trials

Efficacy of an Automatic Toothbrush

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to compare the efficacy in terms of bacterial plaque removal, in a single use, of a new Y-shaped automatic electric toothbrush with nylon bristles, compared with the electric toothbrush of similar shape but with silicone bristles, with the manual toothbrush, and with a negative control (no brushing) in a group of volunteer students. Primary endpoint: difference in "full mouth plaque score" between before and after brushing. Secondary endpoint: sensation of "clean mouth" assessed on VAS scale from 0 to 10 where 0 indicates no sensation of clean mouth and 10 maximum sensation of clean mouth. Single-center, randomized, controlled, superiority, cross-over, examiner-blinded study with 5 treatments (Y-shaped electric toothbrush with nylon bristles, similarly shaped electric toothbrush with silicone bristles, manual brushing for 45 seconds, manual brushing for 2 minutes, no brushing), carried out in a single session and spaced one week apart.

NCT ID: NCT05593991 Completed - Healthy Clinical Trials

Immediate Repercussions of High Heels on Spine Posture

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The goal of this cross-sectional study is to evaluate the immediate effect of heels elevation on the spine posture in a group of 100 healthy subjects (50 males, 50 females). The main question it aims to answer is weather high heels immediately affects spinal posture and pelvic position in the sagittal plane. Participants will undergo an elevation of 3cm and then 7cm of both heels, while their spine posture will be examined by means of a rasterstereography device.

NCT ID: NCT05593770 Terminated - COVID-19 Clinical Trials

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

NECTAR
Start date: October 27, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening recovery and preventing progression to critical illness, multiorgan failure, or death. Our objective is to determine whether modulating the host tissue response improves clinical outcomes among patients with COVID-19.

NCT ID: NCT05593692 Recruiting - Emergencies Clinical Trials

Gender Differences and Age Related Differences in Emergency Department Admission

SADE
Start date: October 18, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about difference related to age and gender in patients admitted to emergency department.

NCT ID: NCT05593614 Recruiting - Clinical trials for Chemotherapy-induced Peripheral Neuropathy

Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)

ACT
Start date: February 28, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this clinical trial is to compare the efficacy of twice daily applications of ATX01 (10% & 15%) versus placebo during a 12-week treatment period in treating chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivor patients.

NCT ID: NCT05593198 Completed - Atrophy; Bone Clinical Trials

Guided Bone Regeneration Versus Bone Block Grafting

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze the volumetric gain and stability of the newly formed bone tissue comparing guided bone regeneration with block graft.

NCT ID: NCT05592691 Recruiting - Postoperative Pain Clinical Trials

Ropivacaine Plasma Concentrations After Fascial Blocks in Elective Cardio-thoracic and Abdominal Surgery

Start date: April 29, 2022
Phase:
Study type: Observational

Primary aim: observe the incidence of systemic toxicity from local anesthetic (LAST) after performing fascial blocks in patients undergoing elective cardio-thoracic and abdominal surgery. Secondary aim: describe the pharmacokinetic profile of the local anesthetic (ropivacaine) and assess peri-procedural complications, post-operative pain and opiate consumption in the first 24 hours.

NCT ID: NCT05592509 Completed - Inflammation Clinical Trials

Antioxidant Effect of Ozonated Vegetable Oil and Vitamins in Moderately Active Subjects

ANTIOX001
Start date: September 15, 2022
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate the antioxidant effect of a nutraceutical formulation based on vegetable oil and vitamin complex (vitamin K2 and vitamin B9) in subjects with the same level of physical activity (LAF 1.70-1.99, normally active or moderately active).

NCT ID: NCT05592483 Recruiting - Breast Cancer Clinical Trials

An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

DB RESPOND
Start date: July 7, 2023
Phase:
Study type: Observational

This study will collect real-world clinical and patient reported outcomes (PRO) and diary data from eligible patients with documented Human Epidermal Growth Factor Receptor 2 (HER2+) [globally] or HER2-low [North America only] in routine clinical practice.

NCT ID: NCT05592171 Recruiting - HCC Clinical Trials

Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC

SEASON-HCC
Start date: October 17, 2022
Phase: N/A
Study type: Interventional

The goal of this Interventional Study is to compare the efficacy profile and safety of three treatments in patients with HCC nodule. Patients will be randomly divided in three arms: 1. Occlusafe assisted MWA+ DEB-TACE 2. Occlusafe assisted MWA 3. MWA+ DEB-TACE The primary objectives are evaluate the safety of the three treatments; evaluate the effectiveness of treatments one month after the procedure (defined as complete ablation of macroscopic tumor at one month of follow-up), verifying the possible superiority of arm 1 and arm 2 compared to arm 3. The secondary objective is: time to local disease recurrence.